Efficacy of first-line systemic therapy for left-sided primary metastatic colon cancer: a single-centre retrospective cohort analysis of 186 patients

被引：0
|
作者：
Prejac, J. [1 ]
Kekez, D. [2 ]
Belev, B. [3 ]
Plestina, S. [3 ]
机构：
[1] Univ Zagreb, Univ Hosp Ctr Zagreb, Sch Dent Med, Zagreb, Croatia
[2] Univ Hosp Ctr Zagreb, Zagreb, Croatia
[3] Univ Zagreb, Sch Med, Univ Hosp Ctr Zagreb, Zagreb, Croatia
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P - 226
引用
收藏
页数：1
相关论文
共 50 条
  • [1] First-line chemotherapy for metastatic breast cancer in patients ≥75 years: A retrospective single-centre analysis
    Debled, Marc
    Madranges, Nicolas
    Mertens, Cecile
    Durand, Michel
    Brouste, Veronique
    Brain, Etienne
    Mauriac, Louis
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 80 (01) : 171 - 179
  • [2] The best overall response to the first-line but not to the second-line treatment correlates with outcome of metastatic right-sided and left-sided colon cancer
    Ingrid, Garajova
    Giorgio, Frega
    Andrea, Palloni
    Francesca, Abbati
    Maria, Massucci
    Veronica, Mollica
    Giovanni, Brandi
    Guido, Biasco
    ANNALS OF ONCOLOGY, 2017, 28
  • [3] First-line cetuximab improves the efficacy of subsequent bevacizumab for RAS wild-type left-sided metastatic colorectal cancer: an observational retrospective study
    Shousheng Liu
    Chang Jiang
    Lin Yang
    Jinsheng Huang
    Roujun Peng
    Xiaopai Wang
    Wenzhuo He
    Long Bai
    Yixin Zhou
    Bei Zhang
    Liangping Xia
    Scientific Reports, 10
  • [4] First-line cetuximab improves the efficacy of subsequent bevacizumab for RAS wild-type left-sided metastatic colorectal cancer: an observational retrospective study
    Liu, Shousheng
    Jiang, Chang
    Yang, Lin
    Huang, Jinsheng
    Peng, Roujun
    Wang, Xiaopai
    He, Wenzhuo
    Bai, Long
    Zhou, Yixin
    Zhang, Bei
    Xia, Liangping
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [5] Hypofractionated Radiotherapy in Oesophageal Cancer for Patients Unfit for Systemic Therapy: A Retrospective Single-Centre Analysis
    Jones, C. M.
    Spencer, K.
    Hitchen, C.
    Pelly, T.
    Wood, B.
    Hatfield, P.
    Crellin, A.
    Sebag-Montefiore, D.
    Goody, R.
    Crosby, T.
    Radhakrishna, G.
    CLINICAL ONCOLOGY, 2019, 31 (06) : 356 - 364
  • [6] Stenting as first-line management for all patients with nonperforating left-sided obstructing colorectal cancer
    Warden, C.
    Stupart, D.
    Goldberg, P.
    COLORECTAL DISEASE, 2013, 15 (07) : E389 - E395
  • [7] A Single-Centre Experience of First-Line Romiplostim and Immunosuppressive Therapy in Patients With Aplastic Anemia
    Dhingra, Gaurav
    Rajoreya, Ashok
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (04)
  • [8] Solitaire FR as a first-line device in acute intracerebral occlusion: A single-centre retrospective analysis
    Lefevre, Pierre-Henri
    Lainay, Claire
    Thouant, Pierre
    Chavent, Adrien
    Kazemi, Apolline
    Ricolfi, Frederic
    JOURNAL OF NEURORADIOLOGY, 2014, 41 (01) : 80 - 86
  • [9] Gefitinib as the first-line treatment in metastatic adenocarcinoma patients with EGFR mutation-positive: A single-centre retrospective cohort study in Hospital Pulau Pinang, Malaysia
    Appava, Sumithra
    Subramaniam, Deepa Priya Naidu
    Muneswarao, Jaya
    Tan, Ai Lian
    Pereirasamy, Lalitha
    Goon, Ai Khiang
    Muthukumaru, Umadevi
    Ali, Irfhan Ali Hyder
    RESPIROLOGY, 2023, 28 : 318 - 319
  • [10] First-Line Therapy in Metastatic, RAS Wild-Type, Left-Sided Colorectal Cancer: Should Everyone Receive Anti-EGFR Therapy?
    Marco Airoldi
    Michela Bartolini
    Roberta Fazio
    Sara Farinatti
    Valentina Daprà
    Armando Santoro
    Alberto Puccini
    Current Oncology Reports, 2024, 26 (11) : 1489 - 1501
12345